SCHEMBL4513630

SCHEMBL4513630

Cc1nc(S(N)(=O)=O)ccc1NC(=O)COc1cc(C#N)ccc1Oc1cc(Cl)cc(C#N)c1

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 1/20 0.40
SLC2A1 P11166 3/20 0.39
CETP P11597 3/20 0.39
TRPM4 Q8TD43 1/20 0.39
L3MBTL1 Q9Y468 4/20 0.38
LMNA P02545 3/20 0.38
ALDH1A1 P00352 2/20 0.36
SLC22A12 Q96S37 1/20 0.36
HTT P42858 1/20 0.36
ATM Q13315 1/20 0.36
VEGFA P15692 1/20 0.35
EPAS1 Q99814 1/20 0.35
MAPT P10636 1/20 0.35
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
KMT2A Q03164 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4520340 0.97 KCNH2 (0.40) KCNH2SLC2A1CETPTRPM4L3MBTL1
SCHEMBL4521484 0.95 SLC2A1 (0.42) KCNH2SLC2A1CETPL3MBTL1LMNA
SCHEMBL4524261 0.92 SLC2A1 (0.42) KCNH2SLC2A1CETPL3MBTL1LMNA
SCHEMBL4509362 0.90 SLC22A12 (0.42) KCNH2SLC2A1TRPM4L3MBTL1LMNA
SCHEMBL4519188 0.89 KCNJ6 (0.39) KCNH2SLC2A1CETPTRPM4L3MBTL1
SCHEMBL4511385 0.89 L3MBTL1 (0.42) KCNH2SLC2A1CETPL3MBTL1LMNA
SCHEMBL4517583 0.88 CYP3A4 (0.38) KCNH2SLC2A1CETPTRPM4L3MBTL1
SCHEMBL4521806 0.87 SLC2A1 (0.38) KCNH2SLC2A1CETPL3MBTL1SLC22A12
SCHEMBL4519176 0.82 SLC2A1 (0.41) KCNH2SLC2A1CETPL3MBTL1LMNA
SCHEMBL4517665 0.81 SLC2A1 (0.40) KCNH2SLC2A1CETPL3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090264425-A1 CHEMICAL COMPOUNDS PFIZER LIMITED 2009-10-22 US disclosed
US-20090264425-A1 CHEMICAL COMPOUNDS PFIZER LIMITED 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090264425-A1 CHEMICAL COMPOUNDS POLR2E, POLR2A, POLRMT KCNH2 3855/4885SLC2A1 4452/4885CETP 1414/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.